Georgia COVID-19 Response

CORE is providing free COVID-19 relief directly to vulnerable and marginalized communities across Georgia.

Public Health | 2022-now

What is the COVID-19 situation in Georgia?

Throughout the COVID-19 pandemic, Georgia has been one of the hardest-hit areas in the U.S., ranking high among all states for positive case and death counts. It has also held one of the lowest vaccination rates in the nation 

How has CORE helped provide COVID-19 relief in Georgia? 

Since April 2020, CORE has been working with local partners to provide equitable access to COVID-19 relief, targeting marginalized and vulnerable populations who have been devastated by the pandemic.

  

CORE’s efforts Georgia have been quickly adapting to community needs throughout the pandemic, and include operating a free mass COVID-19 testing site at Mercedes-Benz Stadium, an innovative mobile testing unit operation bringing services directly to communities, Case Investigation and Resource Coordination program, and a statewide mobile vaccination program. 

What are CORE’s current COVID-19 relief efforts in Georgia?

With our partners, CORE continues to operate a statewide mobile vaccination program that brings life-saving vaccines directly to marginalized and hard-to-reach populations across Georgia. Our local teams also run communication and community outreach, health equity services, and community mobilizer programs. 

600,000

vaccines administered

122,000

through mobile vaccination events

411,000

tests administered

FAQ. 

Adult, pediatric, and infant COVID-19 vaccines are currently available for all Georgians age 6 months and older. We offer primary series, additional vaccine doses, and boosters. Additional vaccine doses are for immunocompromised patients.  

Everyone ages 5 years and older should get one booster after completing their COVID-19 vaccine primary series. The CDC recommends a second booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine at least four months after the first booster for adults ages 50 years and older and people who are moderately or severely immunocompromised.  

Three COVID-19 vaccines have been granted FDA Emergency Use Authorization (EUA) – Pfizer, Moderna and Johnson & Johnson. Only Pfizer’s COVID-19 vaccine has been authorized for use in individuals under the ages of 18.  

Georgia allocates doses of each vaccine weekly which are distributed to providers throughout the state. 

Infant vaccines are available for ages 6 months to age 5. Pediatric vaccines are available for ages 5-11. Adult vaccines are available for ages 12 years and older.  

Currently, CORE supports our partners at the Georgia Department of Public Health to administer monkeypox vaccine services at select sites in Metro Atlanta. CORE will provide an update if/when we provide direct monkeypox services.  

CORE offers COVID-19 vaccination services and support services to promote vaccination sites and guide site partners with outreach efforts through digital communications and direct community outreach, and develop equitable access to vaccines through site development in Georgia.

 

CORE provides health equity services for vaccination site support, community outreach and mobilization, and community-based organization resource support.  

For more information on COVID-19 vaccines in Georgia, visit the Georgia Department of Public Health.

You can help empower communities.

CORE’s work in Georgia and across the globe is made possible by your generous support. Together, we are creating a brighter, more equitable future.

#community #resilience